Ekso bionics says covid-19 has caused order delays

Ekso bionics provides covid-19 business update and reports preliminary first quarter 2020 financial results.sees q1 2020 revenue $1.4 million to $1.5 million.ekso bionics holdings - as of april 7, regained compliance with minimum bid price requirement required by listing rules of nasdaq.ekso bionics holdings - covid-19 pandemic impacted business in q1 as customers shifted their priorities to prepare for and manage their business.ekso bionics holdings - to reduce expenses and adjust operations to match customer needs, company has furloughed a portion of its workforce.ekso bionics holdings - covid-19 pandemic impacted business in q1, has caused many customers to delay orders typically booked in last few weeks of quarter.
EKSO Ratings Summary
EKSO Quant Ranking